Intermolecular, Inc.
IMI
IMI was delisted on the 19th of September, 2019.
25 hedge funds and large institutions have $17.9M invested in Intermolecular, Inc. in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
2% less capital invested
Capital invested by funds: $18.3M → $17.9M (-$329K)
7% less funds holding
Funds holding: 27 → 25 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$138K |
| 2 |
AL
Aspiriant LLC
Los Angeles,
California
|
+$70.2K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$57K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$29K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$12.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$26.4K |
| 2 |
CPA
Cowen Prime Advisors
New York
|
-$26.1K |
| 3 |
SIM
Spark Investment Management
New York
|
-$15.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11.9K |
| 5 |
Goldman Sachs
New York
|
-$11K |
IMI Hedge Fund Activity: Q1 2017 in Review
25 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q1 2017, worth a combined $17.9M — down 1.8% from $18.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IMI positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $138K. The largest seller was T. Rowe Price Associates, cutting an estimated $26.4K.
- 25 institutional investors held Intermolecular, Inc. (IMI) as of Q1 2017, down from 27 in Q4 2016.
- Funds reported $17.9M of Intermolecular, Inc. stock for Q1 2017, down 1.8% quarter-over-quarter.
- 5 funds opened new Intermolecular, Inc. positions in Q1 2017 and 4 closed out, a net change of +1 holder.
- The largest Intermolecular, Inc. buyer in Q1 2017 was BlackRock, an estimated $138K added.
- The largest Intermolecular, Inc. seller in Q1 2017 was T. Rowe Price Associates, an estimated $26.4K sold.
Based on aggregated 13F filings for Q1 2017.